CytomX Therapeutics, Inc. (CTMX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
CytomX Therapeutics (CTMX) Q1 2026: Cash Runway Extends to 2028 as Varsetta-M Enrollment Hits 113
May 08, 2026
-
CytomX (CTMX) Q4 2025: Varsetta-M Delivers 32% ORR at 10mg, Accelerating CRC ADC Path
March 16, 2026
-
CytomX (CTMX) Q3 2025: CX2051 Study Enrollment Surges to 100, Pivots Toward Registrational Path
November 07, 2025
-
CyTOMICS (CTMX) Q2 2025: $100M Raise Extends Runway, CX2051 Data Sets Stage for CRC Push
August 08, 2025